SCNIのPER（株価収益率）は？

Scinai Immunotherapeutics LTD（SCNI）は現在PER 0.36倍で取引されています。

SCNIのROE（自己資本利益率）は？

Scinai Immunotherapeutics LTDのROEは-22.84%です。

SCNIの配当利回りは？

Scinai Immunotherapeutics LTDの配当利回りは0.00%です。

SCNIの品質スコア（Quality Score）は？

当社のAIはSCNIの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

SCNIは今が買い時ですか？

当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

SCNIはどのセクターに属しますか？

Scinai Immunotherapeutics LTDはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

SCNI (NASDAQ) 株価分析 | Scinai Immunotherapeutics LTD

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

SCNI AI Analysis Summary

Our AI summary for SCNI: Scinai Immunotherapeutics LTD (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.36, ROE of -22.84%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SCNI

Scinai Immunotherapeutics LTD

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 0.25

-0.00 (-0.08%) Day Change

Watchlist Portfolio Compare Chart

0.36

P/E

0.05

D/E

-22.8%

ROE

-15.3%

ROA

0.00%

Div Yield

SCINAI IMMUNOTHERAPEUTICS LTD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.25 Price -0.00 (-0.08%) Day Change	NEWS SCORE: N/A

SCNI, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.25
PBV / Sector	0.11 / 44,105.10 GREAT
Earning Per Share	-0.52

PE / Sector	0.36 / 19.37 GREAT
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	0.21 M GREAT
Average 1W Daily Value	0.32 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-174.68 / 97.23
NPM Average (%) / Sector	-26.48 / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-15.27 / 185,260.64
ROA Average (%) / Sector	-21.94 / 36,684.64
ROA Change Average (%) / Sector	-125.28 / 422,221.42
ROE (%) / Sector	-22.84 / 243,761.81
ROE Average (%) / Sector	78.86 / 48,758.38 GREAT
ROE Change Average (%) / Sector	-128.50 / 424,967.86
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

登録情報

Analyze Date	2026-08-06 08:00:39
Symbol	SCNI
Name	SCINAI IMMUNOTHERAPEUTICS LTD
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	5.17 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1.29 / 9,702.21

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Jerusalem BioPark, Jerusalem, Israel

Phone: 972 8 930 2529

Website: https://www.scinai.com

Sector: Healthcare >> Biotechnology

Description: Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical method development, process development, and cGMP manufacturing of clinical-stage materials to early-stage biotechnology companies. It has collaboration partnerships with Max Planck Society and University Medical Center Gottingen for the development of NanoAb candidates; and Recipharm Israel Ltd for the development of biologics and small-molecule programs. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is based in Jerusalem, Israel.